Amyloid, p‐tau, neurofilament light, and α‐synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease
- DOI
- 10.1002/dad2.70498
- Published
- 2026-10
- Container
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/dad2.70498,
title = {Amyloid, p‐tau, neurofilament light, and α‐synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease},
author = {Marianna Rizzo and Charlotte E. Teunissen and Henrik Zetterberg and Kaj Blennow and Gwendlyn Kollmorgen and Rejko Krüger and Sara B. G. Fernandes and Dag Aarsland and Olga Borejko and Michele Hu and Davit Chokoshvili and Jort E. G. B. Vijverberg and Afina W. Lemstra and Betty M. Tijms and Gabor C. Petzold and Kathrin Brockmann and Thomas Gasser and Giovanni B. Frisoni and Jakub Hort and Zuzana Nedelska and Ann‐Cecilie Hopøy and Tormod Fladby and Frank Jessen and Emrah Düzel and Annika Spottke and Günter U. Höglinger and Sophie Mutel and Claire Chevalier and Rajaraman Krishnan and Pieter Jelle Visser and Stephanie J. B. Vos and Unknown},
year = {2026},
journal = {Alzheimer's \& Dementia: Diagnosis, Assessment \& Disease Monitoring},
doi = {10.1002/dad2.70498},
url = {https://doi.org/10.1002/dad2.70498}
}RIS
TY - JOUR TI - Amyloid, p‐tau, neurofilament light, and α‐synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease AU - Marianna Rizzo AU - Charlotte E. Teunissen AU - Henrik Zetterberg AU - Kaj Blennow AU - Gwendlyn Kollmorgen AU - Rejko Krüger AU - Sara B. G. Fernandes AU - Dag Aarsland AU - Olga Borejko AU - Michele Hu AU - Davit Chokoshvili AU - Jort E. G. B. Vijverberg AU - Afina W. Lemstra AU - Betty M. Tijms AU - Gabor C. Petzold AU - Kathrin Brockmann AU - Thomas Gasser AU - Giovanni B. Frisoni AU - Jakub Hort AU - Zuzana Nedelska AU - Ann‐Cecilie Hopøy AU - Tormod Fladby AU - Frank Jessen AU - Emrah Düzel AU - Annika Spottke AU - Günter U. Höglinger AU - Sophie Mutel AU - Claire Chevalier AU - Rajaraman Krishnan AU - Pieter Jelle Visser AU - Stephanie J. B. Vos AU - Unknown PY - 2026 JO - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring DO - 10.1002/dad2.70498 UR - https://doi.org/10.1002/dad2.70498 ER -
APA
Rizzo, M., Teunissen, C. E., Zetterberg, H., Blennow, K., Kollmorgen, G., Krüger, R., Fernandes, S. B. G., Aarsland, D., Borejko, O., Hu, M., Chokoshvili, D., Vijverberg, J. E. G. B., Lemstra, A. W., Tijms, B. M., Petzold, G. C., Brockmann, K., Gasser, T., Frisoni, G. B., Hort, J., Nedelska, Z., Hopøy, A., Fladby, T., Jessen, F., Düzel, E., Spottke, A., Höglinger, G. U., Mutel, S., Chevalier, C., Krishnan, R., Visser, P. J., Vos, S. J. B., & Unknown (2026). Amyloid, p‐tau, neurofilament light, and α‐synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.70498
Source records
- crossref · retrieved 2026-11-10T19:06:46.545Z